icometrix's MRI measures for people with Multiple Sclerosis receive Medtech Innovation briefing from the National Institute for Health and Care Evidence (NICE).
In: PR Newswire, 2022-04-21
Zeitungsartikel
Zugriff:
Titel: |
icometrix's MRI measures for people with Multiple Sclerosis receive Medtech Innovation briefing from the National Institute for Health and Care Evidence (NICE).
|
---|---|
Zeitschrift: | PR Newswire, 2022-04-21 |
Veröffentlichung: | 2022 |
Medientyp: | Zeitungsartikel |
Sonstiges: |
|